Howard Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$415K Buy
14,549
+1,942
+15% +$51.7K 0.04% 152
2026
Q2
$304K Buy
12,607
+1,518
+14% +$39.7K 0.03% 174
2026
Q1
$311K Buy
11,089
+301
+3% +$8.01K 0.04% 167
2025
Q4
$269K Buy
+10,788
New +$272K 0.03% 167
2025
Q1
– Sell
-11,922
Closed -$316K – 191
2024
Q4
$316K Sell
11,922
-1,299
-10% -$35.2K 0.04% 140
2024
Q3
$383K Buy
13,221
+511
+4% +$14.9K 0.06% 110
2024
Q2
$356K Buy
12,710
+156
+1% +$4.3K 0.06% 108
2024
Q1
$348K Buy
12,554
+495
+4% +$13.7K 0.06% 111
2023
Q4
$347K Buy
+12,059
New +$365K 0.07% 111
2023
Q3
– Sell
-5,779
Closed -$212K – 154
2023
Q2
$212K Sell
5,779
-6
-0.1% -$234 0.05% 129
2023
Q1
$236K Buy
5,785
+1,393
+32% +$60.2K 0.06% 120
2022
Q4
$225K Buy
+4,392
New +$211K 0.06% 121
2022
Q1
– Sell
-4,616
Closed -$273K – 147
2021
Q4
$273K Buy
+4,616
New +$229K 0.08% 99

Other funds holding PFE

Howard Financial Services's PFE Position: Q3 2026 in Review

Howard Financial Services increased its Pfizer (PFE) stake by 15% in Q3 2026, buying an estimated $51.7K and bringing the position to 14,549 shares worth $415K. The position accounts for 0.04% of the portfolio, ranked #152.

Howard Financial Services first reported a position in PFE in Q4 2021 and has held it in 13 quarters since. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Howard Financial Services held 14,549 shares of Pfizer worth $415K as of Q3 2026.
  • Howard Financial Services bought 1,942 Pfizer shares in Q3 2026, an estimated $51.7K.
  • Pfizer made up 0.04% of Howard Financial Services's portfolio in Q3 2026, its #152 holding.
  • Howard Financial Services first reported a position in Pfizer in Q4 2021 and has held it in 13 quarters since.
  • 2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Howard Financial Services's 13F filing for Q3 2026, filed 15 Oct 2026.